Pfizer Inc (PFE)

Operating profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Operating income (ttm)	US$ in thousands	14,909,000	10,129,000	1,580,000	1,970,000	3,793,000	11,818,000	25,510,000	36,188,000	40,492,000	38,103,000	34,149,000	26,509,000	20,525,000	14,292,000	11,147,000	9,293,000	8,759,000	12,934,000	12,929,000	13,627,000
Revenue (ttm)	US$ in thousands	63,627,000	60,113,000	55,643,000	55,094,000	58,497,000	68,538,000	77,944,000	92,952,000	100,331,000	99,879,000	101,335,000	92,570,000	81,491,000	69,337,000	57,374,000	50,198,000	47,644,000	48,648,000	49,197,000	50,660,000
Operating profit margin		23.43%	16.85%	2.84%	3.58%	6.48%	17.24%	32.73%	38.93%	40.36%	38.15%	33.70%	28.64%	25.19%	20.61%	19.43%	18.51%	18.38%	26.59%	26.28%	26.90%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $14,909,000K ÷ $63,627,000K
= 23.43%

Pfizer Inc's operating profit margin has shown fluctuations over the reported periods. The margin started at 26.90% in March 2020, then slightly decreased to 18.38% by December 2020. There was a subsequent increase in the margin to 33.70% by June 2022, followed by a peak at 40.36% in December 2022. However, the margin declined significantly to 3.58% by March 2024 and further dropped to 2.84% by June 2024. The margin then recovered to 23.43% by December 2024.

The range of operating profit margins ranged from a low of 2.84% to a high of 40.36% during this period. It is evident that there have been periods of both expansion and contraction in Pfizer Inc's operating profit margins. It would be important to further investigate the reasons behind these fluctuations to assess the company's operational efficiency and profitability sustainability.